ORIC Pharmaceuticals, Inc.ORICNASDAQ
Loading
EBITDA Over TimeContracting
Percentile Rank0
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Latest
$-128.25M
↓ 79% vs avg
Percentile
P0
Near historical low
Streak
7 yr
Consecutive declineContracting
Average
$-71.60M
Historical baseline
PeriodValueYoY Change
2025$-128.25M-1.2%
2024$-126.74M-15.5%
2023$-109.75M-27.9%
2022$-85.80M-10.0%
2021$-77.97M-61.2%
2020$-48.37M-86.9%
2019$-25.88M-26.5%
2018$-20.46M+3.2%
2017$-21.13M-